Provider-initiated testing and counselling for human immunodeficiency virus among tuberculosis patients in Guangxi

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 7, 2010, Pages 921-923

  Wang, X W ^a,b   Liu, Y ^a   Dong, B Q ^b   Liu, F Y ^b   Chen, Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HIV/AIDS Clinic   (China)

Author keywords

Co infection; HIV infection; PITC; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CHINA; FEMALE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATIENT; PATIENT ATTITUDE; PRIORITY JOURNAL; PROVIDER INITIATED TESTING AND COUNSELLING; TUBERCULOSIS; ADOLESCENT; AGED; CHILD; COMPLICATION; DIRECTIVE COUNSELING; HIV INFECTIONS; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; PROCEDURES; SERODIAGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS SERODIAGNOSIS; CHILD; CHILD, PRESCHOOL; CHINA; DIRECTIVE COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; TUBERCULOSIS; YOUNG ADULT;

EID: 77953642758     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Stop TB Partnership. The Global Plan to Stop TB, 2006-2015. Part II: Global and regional scenarios for TB control 2006-2015. Geneva, Switzerland: WHO. http://www.stoptb.org/global/plan/ main/part2.asp Accessed April 2010.
2. World Health Organization. Interim policy on collaborative TB/HIV activities. WHO/HTM/TB/2004.330. Geneva, Switzerland: WHO, 2004. http://www.who.int/tb/publications/tbhiv-interim-policy/en/ Accessed April 2010.
3. World Health Organization. Guidelines for HIV surveillance among tuberculosis patients. WHO/HTM/TB/2004.339. 2nd ed. Geneva, Switzerland: WHO, 2004. http://whqlibdoc.who.int/ hq/2004/WHO-HTM-TB-2004.339.pdf Accessed April 2010.
4. Fitzgerald D W, Desvarieux M, Severe P, Joseph P, Johnson W D Jr, Pape J W. Effect of post-treatment isoniazid on prevention of recurrent TB in HIV-1-infected individuals: a randomised trial. Lancet 2000; 356: 1470-1474.
5. Daley C L. TB recurrence in Africa: true relapse or re-infection? Lancet 1993; 342: 756-757 (commentary).
6. Sonnenberg P, Murray J, Glynn J, et al. HIV-1 and recurrence, relapse, and re-infection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693.
7. Reid A, Scano F, Getahun H, et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006; 6: 483-495.
8. National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis. Office of the Nationwide Epidemiological Sampling Survey for Tuberculosis. Report on nationwide random survey for the epidemiology of tuberculosis in 2000. J Chinese Anti-Tuberc Assoc 2002; 24: 65-108.
9. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/ 2005.349. Geneva, Switzerland: WHO, 2005.